Search results for "High flow"

High flow nasal therapy in immunocompromised patients with acute respiratory failure: A systematic review and meta-analysis.

2019

Abstract Purpose The role of high-flow nasal therapy (HFNT) as compared to conventional oxygen therapy (COT) in immunocompromised patients admitted to intensive care unit (ICU) with acute respiratory failure (ARF) remains unclear. We conducted a systematic review and meta-analysis in order to address this issue. Methods We searched PubMed, Medline and Embase until November 7th, 2018. Randomized controlled trials (RCTs), non-randomized prospective and retrospective evidence were selected. Observational studies were considered for sensitivity analysis. Primary outcome was mortality rate; intubation rate was a secondary outcome. Results We included four studies in the primary analysis: one RCT…

Weaning Premature Infants from Nasal Continuous Positive Airway Pressure - Current Practice and Scientific Evidence.

2017

Abstract Objective In the past decade, a number of trials have been conducted to determine the optimal strategy of weaning premature infants from nasal continuous airway pressure (nCPAP). However, a paucity of information exists on how weaning is actually performed in clinical routine. Aim of this study was to investigate the current practice of weaning premature infants from nCPAP in Germany. Methods An online survey was performed in German tertiary care neonatal units. Results All 160 German tertiary care units were contacted. Replies were retrieved from 85/160 (53%) units, of which 83/160 (52%) completed the questionnaire. 66/83 (80%) respondents indicated to wean without the use of form…

Estudio comparativo de la combinación de diferentes modos de administración de anestésicos locales en la analgesia del parto

2020

La analgesia epidural es una de las técnicas más demandadas y por ello dicha analgesia ha ido evolucionando en los últimos años. Recientemente se ha desarrollado el modo PIEB (Programmed Intermittent Epidural Boluses) que puede reducir el consumo de anestésico local y así minimizar consecuencias indeseables tales como la cardio o la neurotoxicidad. En el año 2012 la compañía Smiths Medical lanzó al mercado un sistema de infusión ambulatoria CADD®-Solis versión software 3.0 de la generación de bombas de infusión CADD® que permite combinar varios modos de administración del anestésico local en el espacio epidural, hasta ahora no utilizados juntos ya que no existía en el mercado una bomba con …

Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate

2019

Informazione non disponibile

Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient? Pro

2019

High Flow Nasal Therapy Use in Patients with Acute Exacerbation of COPD and Bronchiectasis: A Feasibility Study

2020

The efficacy and feasibility of high flow nasal therapy (HFNT) use in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and bronchiectasis is unknown. We performed a single-center, single-arm prospective observational study in patients with AECOPD, documented bronchiectasis, pH >= 7.35, respiratory rate (RR) >= 26 breaths/minute despite receiving maximal medical treatment and oxygen via face mask up to 10 L/m. Patients received HFNT (Airvo 2, Fisher & Paykel) at a gas flow of 50 L/min and FIO2 adjusted to maintain SpO(2) >= 92%. Dyspnea, rated by Borg scale, RR, arterial blood gases and mucus production (ranging from 1 to 3) were collected befor…

Non-invasive mechanical ventilation and high-flow oxygen therapy in the COVID-19 pandemic: the value of a draw

2021

Healon®5: A New Viscoadaptive Formulation

2000

To relate the practical relevance of our study results, specific requirement profiles for individual procedures have been correlated to the desired physicochemical characteristics. Healon®5 demonstrated the statistically significant highest zero shear viscosity of all OVD and a long relaxation time (Dick et al., 2000). It therefore most effectively creates and maintains a deep anterior chamber in order to facilitate safe surgical maneuvers (e.g., in case of vitreous pressure). Additionally, the high viscosity of Healon®5 exhibits a dynamic frequency dependence, which has not been observed in any pure hyaluronic acid formulation before. Healon®5’s properties change in response to surgical ma…

Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections

2020

ABSTRACTIntroductionNoninvasive respiratory support (NRS) such as noninvasive ventilation (NIV) and high flow nasal therapy (HFNT) have been used in the treatment of acute hypoxemic respiratory failure (AHRF) related to the coronavirus disease (COVID-19) and other viral infections. However, there is a lack of consensus in favor of or against NRS use due to the risks of worsening hypoxemia, intubation delay, and aerosols environmental contamination associated with the use of these tools. We aimed to summarize the evidence on the use of NRS in adult patients with COVID-19 and other viral pneumonia (i.e. H1N1, SARS, MERS) and AHRF. We also searched for studies evaluating the risk of aerosoliza…

High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized…

2020

Abstract Background The efficacy and safety of high flow nasal therapy (HFNT) in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease (AECOPD) are unclear. Our aim was to evaluate the short-term effect of HFNT versus NIV in patients with mild-to-moderate AECOPD, with the hypothesis that HFNT is non-inferior to NIV on CO2 clearance after 2 h of treatment. Methods We performed a multicenter, non-inferiority randomized trial comparing HFNT and noninvasive ventilation (NIV) in nine centers in Italy. Patients were eligible if presented with mild-to-moderate AECOPD (arterial pH 7.25–7.35, PaCO2 ≥ 55 mmHg before ventilator support). Primary endpoint was the mean di…